Wenbin Qian
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma. (NCT03929107) | Wenbin Qian | 2019-03-28 |
Track Wenbin Qian automatically
Every clearance here is in the API, with alerts when new ones post.